Intra-Cellular Therapies Statistics
Total Valuation
Nasdaq has a market cap or net worth of EUR 47.97 billion. The enterprise value is 55.69 billion.
Market Cap | 47.97B |
Enterprise Value | 55.69B |
Important Dates
The last earnings date was Wednesday, July 23, 2025.
Earnings Date | Jul 23, 2025 |
Ex-Dividend Date | Jun 13, 2025 |
Share Statistics
Current Share Class | 573.80M |
Shares Outstanding | n/a |
Shares Change (YoY) | +5.21% |
Shares Change (QoQ) | -0.17% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 511.57M |
Valuation Ratios
The trailing PE ratio is 37.36 and the forward PE ratio is 27.57.
PE Ratio | 37.36 |
Forward PE | 27.57 |
PS Ratio | 6.95 |
PB Ratio | 4.77 |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 21.22, with an EV/FCF ratio of 30.65.
EV / Earnings | 43.37 |
EV / Sales | 7.96 |
EV / EBITDA | 21.22 |
EV / EBIT | 27.94 |
EV / FCF | 30.65 |
Financial Position
The company has a current ratio of 0.96, with a Debt / Equity ratio of 0.82.
Current Ratio | 0.96 |
Quick Ratio | 0.21 |
Debt / Equity | 0.82 |
Debt / EBITDA | 3.25 |
Debt / FCF | 4.54 |
Interest Coverage | 5.70 |
Financial Efficiency
Return on equity (ROE) is 13.25% and return on invested capital (ROIC) is 6.59%.
Return on Equity (ROE) | 13.25% |
Return on Assets (ROA) | 4.64% |
Return on Invested Capital (ROIC) | 6.59% |
Return on Capital Employed (ROCE) | 9.90% |
Revenue Per Employee | 727,614 |
Profits Per Employee | 135,278 |
Employee Count | 9,162 |
Asset Turnover | 0.27 |
Inventory Turnover | n/a |
Taxes
In the past 12 months, Nasdaq has paid 277.59 million in taxes.
Income Tax | 277.59M |
Effective Tax Rate | 17.79% |
Stock Price Statistics
The stock price has increased by +33.58% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | +33.58% |
50-Day Moving Average | 77.49 |
200-Day Moving Average | 74.14 |
Relative Strength Index (RSI) | 65.47 |
Average Volume (20 Days) | 138 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | 1.49 |
Income Statement
In the last 12 months, Nasdaq had revenue of EUR 6.91 billion and earned 1.28 billion in profits. Earnings per share was 2.21.
Revenue | 6.91B |
Gross Profit | 4.19B |
Operating Income | 1.92B |
Pretax Income | 1.56B |
Net Income | 1.28B |
EBITDA | 2.44B |
EBIT | 1.92B |
Earnings Per Share (EPS) | 2.21 |
Balance Sheet
The company has 632.66 million in cash and 8.25 billion in debt, giving a net cash position of -7.62 billion.
Cash & Cash Equivalents | 632.66M |
Total Debt | 8.25B |
Net Cash | -7.62B |
Net Cash Per Share | n/a |
Equity (Book Value) | 10.06B |
Book Value Per Share | 17.52 |
Working Capital | -259.71M |
Cash Flow
In the last 12 months, operating cash flow was 2.01 billion and capital expenditures -190.74 million, giving a free cash flow of 1.82 billion.
Operating Cash Flow | 2.01B |
Capital Expenditures | -190.74M |
Free Cash Flow | 1.82B |
FCF Per Share | n/a |
Margins
Gross margin is 60.60%, with operating and profit margins of 27.75% and 18.59%.
Gross Margin | 60.60% |
Operating Margin | 27.75% |
Pretax Margin | 22.59% |
Profit Margin | 18.59% |
EBITDA Margin | 35.37% |
EBIT Margin | 27.75% |
FCF Margin | 26.31% |
Dividends & Yields
This stock pays an annual dividend of 0.90, which amounts to a dividend yield of 1.09%.
Dividend Per Share | 0.90 |
Dividend Yield | 1.09% |
Dividend Growth (YoY) | 7.89% |
Years of Dividend Growth | 13 |
Payout Ratio | 37.73% |
Buyback Yield | -5.21% |
Shareholder Yield | -4.12% |
Earnings Yield | 2.68% |
FCF Yield | 3.79% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | |
Lynch Upside | |
Graham Number | |
Graham Upside |
Stock Splits
The last stock split was on August 29, 2022. It was a forward split with a ratio of 3.
Last Split Date | Aug 29, 2022 |
Split Type | Forward |
Split Ratio | 3 |
Scores
Nasdaq has an Altman Z-Score of 2.32 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 2.32 |
Piotroski F-Score | 7 |